Findings from this study suggests that when pregnant people disclosed drug use, clinicians were more likely to order urine drug testing for Black pregnant people compared with their White counterparts, suggesting clinician racial bias. Current practice patterns and protocols such as urine drug testing in pregnancy care deserve review to identify and mitigate areas of potential clinician discrimination.
References
Chang JC, Holland CL, Tarr JA, Rubio D, Rodriguez KL, Kraemer KL, et al. Perinatal illicit drug and marijuana use. Am J Health Promot 2017;31:35–42.
Berra A, Kamo S, Mohnot S, Rosselot J, Suire A, Stafford J, et al. The association between antenatal maternal self-reported substance use, maternal characteristics, and obstetrical variables. J Addict Med 2019;13:464–9.
Jarlenski M, Hogan C, Bogen DL, Chang JC, Bodnar LM, Van Nostrand E. Characterization of U.S. state laws requiring health care provider reporting of perinatal substance use. Womens Health Issues 2017;27:264–70.
Please Sign in (or Register) to view further.